期刊文献+

宫颈癌新辅助化疗敏感性的影响因素研究 被引量:7

Factors associated with sensitivity of neoadjuvant chemotherapy in cervical cancer
下载PDF
导出
摘要 目的:探讨影响宫颈癌患者新辅助化疗(NACT)敏感性的相关因素。方法:回顾分析2011年4月至2015年2月天津市中心妇产科医院收治的106例IB2~IIB期宫颈癌患者资料,行NACT 1~3个疗程,术前评价治疗效果。分析病理类型、临床分期、肿瘤直径、组织学分级、治疗前血清鳞状上皮抗原(SCC-Ag)、血红蛋白、血小板、血小板与淋巴细胞比值(PLR)与NACT敏感性的关系。结果:NACT有效率为64.15%(68/106)。NACT有效组的手术时间、术后淋巴结转移率、宫颈深间质浸润率均低于无效组(P〈0.05)。单因素分析显示,治疗前肿瘤直径、SCC-Ag、PLR与宫颈癌NACT敏感性有关(P〈0.05)。多因素分析显示,治疗前肿瘤直径、SCC-Ag、PLR是影响宫颈癌NACT敏感性的独立危险因素(P〈0.05)。结论:治疗前肿瘤直径、SCC-Ag、PLR对宫颈癌NACT的敏感性有一定的预测价值。 Objective:To explore the effective factors for sensitivity of neoadjuvant chemotherapy(NACT) in cervical cancer. Methods:Stage IB2 to IIB disease was present in 106 patients which were all undertaken 1 - 3 courses of NACT and radical hysterectomy in our hos- pital during Apr. 2011 and Feb. 2015. Efficacy lationship of NACT sensitivky with pathological was evaluated preoperatively. To analyze the re- type, clinical stage, tumor diameter, grade of dif- ferentiation,pretreatment level of serum squamous cell carcinoma antigen (SCC-Ag), hemoglo- bin, platelets, platelet and lymphocyte ratio (PLR). Results:The efficiency was 64.15% (68/ 106). Time of operation and the rate of lymph node metastasis and cervical deep stromal infil- tration in effective group was significantly lower than that in invalid group (P〈0. 05 ). Univariate analysis showed that pretreatment tumor diameter, SCC-Ag, PLR was significantly related to NACT sensitivity ( P〈0.05 ). Multivariate analysis showed those pretreatment tumor diameter, SCC-Ag,PLR were independently correlated with NACT sensitivity in cervical cancer (P 〈 0.05 ). Conclusions: Pretreatment tumor diameter, SCC-Ag and PLR showed potentially predic- tive value of NACT sensitivity in cervical cancer.
作者 赵晓南 张虹
出处 《现代妇产科进展》 CSCD 北大核心 2015年第7期498-500,共3页 Progress in Obstetrics and Gynecology
关键词 宫颈癌 新辅助化疗 敏感性 血小板与淋巴细胞比值 Cervical cancer Neoadjuvant chemotherapy (NACT) Sensitivity Platelet and lymphocyte ratio (PLR)
  • 相关文献

参考文献13

  • 1Stamatis G. Risks of neoadjuvant chemotherapy and radia- tion therapy[ J ]. Thorac Surg Clin,2008,18 ( 1 ) :71-80.
  • 2Chela HJ,Liang C,Zhang L,et al. Clinical efficacy of modi- fied preoperative neoadjuvant chemotherapy in the treat- ment of locally advanced ( stage IB2 to lIB) cervical canc- er:randomized study [ J ]. Gynecol Oncol, 2008,110 ( 3 ) : 308-315.
  • 3Stone RL, Nick AM, Mcneish IA, et al. Paraneoplastic thromboeytosis in ovarian cancer [ J ].N Engl J Med, 2012,366(7) :610-618.
  • 4Yuan L, Liu XS. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism [ J ]. Mol Med Rep,2015,11 (4) :2449-2458.
  • 5罗亚,越太迁,傅移山,成正军,张可,饶华.影响老年原发性结直肠癌术后疗效的因素分析[J].实用癌症杂志,2014,29(8):1005-1007. 被引量:2
  • 6Hanahan D, Weinberg R. Hallmarks of cancer:the next generation [ J ]. Cell,2011,144 (5) :646-674.
  • 7Wang D, Yang JX, Cao DY, et al. Preoperative neutrophil- lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma[ J ]. Onco Targets T- her,2013,6:211-216.
  • 8周文毓,陈金婵,惠宁.治疗前血小板和淋巴细胞比值与宫颈癌新辅助化疗疗效及预后的相关性[J].中国肿瘤临床,2014,41(16):1045-1048. 被引量:15
  • 9Yin MZ, Hou Y, Zhang T, et al. Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients:a prospective cohort study [ J ]. PLoS One ,2013,8( 1 ) : e54969.
  • 10Sugiyama T, Nishida T, Hasuo Y, et al. Neoadjuvant in- traarterial chemotherapy followed by radical hysterectomy and for radiotherapy for locally advanced cervical cancer [ J ]. Gyneeol Oncol, 1998,69 (2) : 130-136.

二级参考文献37

共引文献19

同被引文献62

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部